How Much GLP-1 to Take: Dosing Guide for Weight Loss

Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery

Key Takeaways for Safe GLP-1 Dosing

• GLP-1 dosing is never one-size-fits-all. Protocols start low and increase slowly based on your tolerance and lab markers.

• Compounded semaglutide usually begins at 0.25 mg weekly and compounded tirzepatide at 2.5 mg weekly, with four-week increases.

• Accurate unit-to-milligram conversions depend on each vial’s concentration, so verified pharmacy sourcing is essential for safety.

• Side effects such as nausea and constipation often improve with smaller low-fat meals, hydration, consistent injection timing, and holding doses when needed.

• Book an appointment with Ellie at Mirror Plastic Surgery for a personalized, lab-guided GLP-1 dosing plan tailored to your metabolic profile.

Meet Ellie Pranckevicius, FNP-BC: Your GLP-1 Dosing Partner

Ellie Pranckevicius is a board-certified Family Nurse Practitioner and the lead peptide therapy clinician at Mirror Plastic Surgery in St. Petersburg, Florida. She holds a Master’s in Nursing from the University of South Florida and spent four years in the Neuroscience ICU at Tampa General Hospital managing complex metabolic and physiological cases. That critical-care background gives her a detailed understanding of how the body responds to dose changes, electrolyte shifts, and hormonal signaling, which directly affects whether a GLP-1 protocol works well or causes avoidable side effects. Ellie began her career as a licensed esthetician at a high-end medical spa in Boston, so she approaches weight management and metabolic health through both an aesthetic and a clinical lens. Every protocol she designs starts with a comprehensive lab panel and a 30–60 minute one-on-one consultation.

Book an appointment with Ellie to discuss your candidacy for compounded GLP-1 or GLP-3R therapy.

How GLP-1 Agonists Work and Why Dosing Must Be Personalized

GLP-1 receptor agonists are peptide-based medications that mimic glucagon-like peptide-1, a hormone naturally released by the gut after you eat. They slow gastric emptying, reduce appetite, stimulate insulin release when glucose is elevated, and lower glucagon levels. Together, these effects support meaningful weight loss and improvements in metabolic markers such as HbA1c, fasting glucose, and lipid panels.¹

Brand-name medications such as Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) come in pre-filled pens with fixed dose increments. Compounded versions are prepared by licensed compounding pharmacies and dispensed in multi-dose vials measured in units drawn with an insulin syringe. Most patient confusion starts here, because the concentration of the vial, expressed as mg/mL, determines how many units equal a specific milligram dose, and that concentration varies by pharmacy and formulation. Because of this variability, dosing must be matched to both the vial concentration and the individual patient.

Individual factors that influence the correct GLP-1 dosage for weight loss include body weight, kidney and liver function, thyroid status, baseline insulin resistance, current medications, and gastrointestinal history. A lab panel that reviews these markers forms the foundation of a safe titration schedule. Mirror Plastic Surgery’s GLP-3R compounding formulation represents a newer-generation option that is reported to have fewer gastrointestinal side effects, a lower risk of muscle loss, and broader metabolic benefits, including cardiovascular risk reduction.

GLP-1 Dosage for Weight Loss: Step-by-Step Titration Schedule

Starting Dose for Compounded Semaglutide

The starting protocol for compounded semaglutide is generally 0.25 mg once weekly, held for four weeks before any increase. Some compounders use slightly different schedules, so patients should confirm the plan with their provider. This approach mirrors the logic of the brand-name pen and gives the GI tract time to adjust to slower gastric motility.

Starting Dose for Compounded Tirzepatide

Compounded tirzepatide usually begins at 2.5 mg once weekly for four weeks. Tirzepatide is a dual GIP/GLP-1 receptor agonist, which means it activates two incretin pathways at the same time. This often produces greater weight loss but also requires careful and gradual dose increases.¹

Sample Supervised Titration Table

Phase	Compounded Semaglutide Dose	Compounded Tirzepatide Dose	Duration Before Escalation
Initiation	0.25 mg/week	2.5 mg/week	4 weeks
Escalation 1	0.5 mg/week	5 mg/week	4 weeks
Escalation 2	1.0 mg/week	7.5 mg/week	4 weeks
Escalation 3	1.7 mg/week	10 mg/week	4 weeks
Maintenance Range	1.7–2.4 mg/week	10–15 mg/week	Ongoing, clinician-reviewed

These ranges reflect general supervised protocols. Individual maintenance doses are set based on clinical response, side effect profile, and ongoing lab review, not a fixed target number. Escalation should pause or move down if side effects become difficult to manage at a specific dose.

GLP-1 Dosing in Units: Converting Units to Milligrams

Compounded GLP-1 vials are drawn with an insulin syringe that uses a U-100 scale, where 100 units equal 1 mL. The milligram dose you inject depends entirely on the concentration of your vial. Use this formula for conversions:

Units to draw = (Desired dose in mg ÷ Vial concentration in mg/mL) × 100

Worked Example 1: 0.25 mg from a 2.5 mg/mL Vial

(0.25 ÷ 2.5) × 100 = 10 units

Worked Example 2: 0.5 mg from a 5 mg/mL Vial

(0.5 ÷ 5) × 100 = 10 units

How to Tell Whether 30 Units Is Too Much

The safety of 30 units depends completely on vial concentration. At 2.5 mg/mL, 30 units equal 0.75 mg, which is a reasonable mid-titration dose for many patients. At 5 mg/mL, 30 units equal 1.5 mg, which is a higher maintenance-range dose suitable only for patients who escalated gradually and tolerate that level well. This difference shows why self-dosing from online vials without verified concentration is dangerous. Always confirm mg/mL with your dispensing pharmacy and supervising clinician before drawing any dose.

Book an appointment with Ellie to receive a verified conversion chart that matches your specific compounded vial.

Reducing Side Effects While You Increase Your GLP-1 Dose

The most common side effects during GLP-1 dose increases are nausea, vomiting, constipation, and fatigue. These effects are dose-dependent and often improve with a few supervised strategies.

Eat smaller, lower-fat meals. GLP-1 activity already slows gastric emptying, and large or high-fat meals can intensify nausea. Smaller portions and lower fat content at each meal are often the most effective behavioral changes during titration.

Stay hydrated and increase dietary fiber gradually. Constipation is common, especially in the first four to eight weeks. Adequate fluids and slow, steady fiber increases usually reduce this risk without extra medications for most patients.

Inject on a consistent day and time. A regular schedule reduces swings in drug levels, which supports more stable tolerability throughout the week.

Hold the dose instead of pushing through severe symptoms. If nausea or vomiting interferes with daily life, the appropriate response is to hold the current dose for another four weeks rather than increasing. Escalating on a rigid calendar, regardless of how you feel, is one of the most common mistakes in unsupervised protocols.

GLP-3R formulations at Mirror Plastic Surgery are reported to have a more favorable gastrointestinal side-effect profile than earlier GLP-1 compounds. This makes them a useful option for patients who stopped previous therapy because of nausea.

Safety Checklist Before Starting Compounded GLP-1 Therapy

Not every patient is a candidate for GLP-1 therapy. Contraindications include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, active pancreatitis, and severe gastroparesis. A thorough pre-treatment lab panel that covers thyroid function, liver enzymes, kidney function, fasting glucose, HbA1c, and a lipid panel is the minimum standard before starting any compounded GLP-1 protocol.

High-quality sourcing protects your safety. Compounded peptides from unverified online retailers do not offer reliable guarantees of concentration accuracy, sterility, or active ingredient content. Mirror Plastic Surgery works only with compounding pharmacies that perform rigorous batch testing and provide documented purity and concentration verification for every vial.

Patients should also understand that compounded GLP-1 and GLP-3R formulations are not FDA-approved drugs. Pharmacies prepare them under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. They require a valid prescription from a licensed clinician after an individualized assessment.

Smart Questions to Ask About GLP-3R Dosing

Before starting any GLP-1 or GLP-3R protocol, a qualified provider should clearly address several key points. Start by confirming the basics: What is the exact mg/mL concentration of the compounded vial, and which pharmacy is compounding it? Once you know the source, ask what batch testing documentation that pharmacy provides to confirm purity and sterility. Next, clarify the monitoring plan by asking which labs will be reviewed before therapy and how often those labs will be repeated. Then discuss how the provider manages common challenges, including their protocol if you experience significant nausea or vomiting and whether they hold, reduce, or increase the dose. Ask how they adjust dosing if your weight loss plateaus before you reach the usual maintenance range. Finally, explore their approach to muscle preservation, including whether they consider complementary peptides such as Sermorelin or Ipamorelin to support lean mass during active weight loss.

A provider who cannot answer these questions with specific details is not prepared to supervise compounded GLP-1 dosing safely.

How GLP-1 Therapy Fits with Other Peptide Protocols

GLP-1 and GLP-3R therapy often work best as part of a broader plan. Many patients pursuing weight loss also struggle with systemic inflammation, and treating both issues together can create more durable metabolic results. Mirror Plastic Surgery’s Glow Stack, which includes GHK-CU, BPC-157, and TB500, targets systemic inflammation, soft tissue repair, and collagen production. This combination can complement a GLP-1 weight loss protocol, especially for patients recovering from surgery or managing inflammatory conditions along with metabolic dysfunction.

Patients who worry about losing lean muscle during calorie reduction may benefit from growth hormone-releasing peptides such as Sermorelin and Ipamorelin. These can support natural growth hormone production and muscle retention when used appropriately. NAD therapy, which supports mitochondrial energy production, is another option for patients who feel fatigued during active weight loss. Ellie makes all stacking decisions after a full lab review and clinical assessment, not as an automatic add-on.

Book an appointment with Ellie to explore whether a combined peptide protocol matches your health profile and goals.

Frequently Asked Questions About GLP-1 Maintenance and Results

How Long It Takes to See Weight Loss Results

Most patients notice appetite suppression and early weight changes within two to four weeks of starting therapy, even at the lowest dose.¹ Meaningful weight loss, often defined as at least five percent of body weight, usually appears within the first three to six months of a supervised titration schedule.¹ Results vary based on starting weight, nutrition, activity level, and individual metabolic response.¹ Patients with significant insulin resistance may see slower early progress that speeds up as metabolic markers improve.¹

What to Expect at a Maintenance Dose

Maintenance dosing begins when weight loss stabilizes and the main goal shifts to sustaining results and tracking metabolic health. Lab panels are repeated at regular intervals to monitor kidney function, liver enzymes, and other metabolic markers. Some patients stay on a fixed maintenance dose long term, while others taper gradually under clinician supervision after reaching target weight and metabolic goals. Stopping GLP-1 therapy abruptly without a transition plan usually leads to appetite returning to baseline and gradual weight regain.

How GLP-1 Therapy Affects Muscle Mass

Rapid weight loss from any cause, including calorie restriction, surgery, or medications, can reduce lean muscle mass. This risk decreases with adequate dietary protein, regular resistance training, and, when appropriate, the addition of growth hormone-releasing peptides. GLP-3R formulations are noted for a lower tendency to cause muscle loss than earlier GLP-1 compounds, which is one reason Mirror Plastic Surgery includes this newer formulation in its weight management protocols.¹

Using Compounded GLP-1 with a Thyroid History

Thyroid history plays a central role in the pre-treatment lab review. Patients with a personal or family history of medullary thyroid carcinoma should not receive GLP-1 therapy. Patients with well-managed hypothyroidism or hyperthyroidism may still qualify, but thyroid function must be documented and monitored throughout the protocol. Ellie makes this determination case by case after a full clinical assessment, not through a generic checklist.

Your Next Steps with GLP-1 Dosing

The correct GLP-1 dose is always the lowest effective dose for you, increased slowly based on how you feel and what your labs show. Compounded GLP-1 and GLP-3R formulations offer flexible, personalized dosing, but that flexibility stays safe only with a qualified clinician, verified pharmacy sourcing, and ongoing metabolic monitoring. Self-dosing from unverified online vials, without confirmed concentration, pre-treatment labs, or clinical support, creates risks that outweigh any savings or convenience.

Mirror Plastic Surgery provides concierge-level GLP-1 and GLP-3R dosing oversight through Ellie Pranckevicius, FNP-BC. Care includes full lab review, individualized titration schedules, unit-to-mg conversion guidance, and 24/7 direct access throughout your protocol. Services are available in-person in St. Petersburg, Florida, and remotely across the United States.

Please note: Compounded GLP-1 and GLP-3R peptides are not FDA-approved for weight loss or metabolic health indications. A qualified, licensed clinician must make all dosing decisions after reviewing your lab results, medical history, and health goals. This article does not replace medical advice or a personalized clinical consultation.

Book an appointment with Ellie to begin your lab-guided GLP-1 dosing protocol at Mirror Plastic Surgery.